Fenofibrate modified-release pellets with lag phase and high oral bioavailability
Fang Li,1,* Xin Zheng,2,* YongChu Bao,3 Ting Chen,3 Jia Zeng,1 XiaoLi Xu,4 Chao Yan,5 LingLin Feng1 1NHC Key Laboratory of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Fudan University, and Shanghai Engineer and Technology Research Center of Reproductive Health Drug a...
Saved in:
Main Authors: | Li F (Author), Zheng X (Author), Bao YC (Author), Chen T (Author), Zeng J (Author), Xu XL (Author), Yan C (Author), Feng LL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Understanding Fenofibrate Release from Bare and Modified Mesoporous Silica Nanoparticles
by: Giorgia Figari, et al.
Published: (2023) -
Oral Modified Release Multiple-Unit Particulate Systems: Compressed Pellets, Microparticles and Nanoparticles
by: Nihad Al-Hashimi, et al.
Published: (2018) -
Development of a tin oxide carrier with mesoporous structure for improving the dissolution rate and oral relative bioavailability of fenofibrate
by: Bai A, et al.
Published: (2018) -
Preparation and evaluation of tamsulosin hydrochloride sustained-release pellets modified by two-layered membrane techniques
by: Jingmin Wang, et al.
Published: (2015) -
Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitis
by: Nabila Ibnou Zekri Lassout, et al.
Published: (2024)